|
FAM118B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.29620000000052E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.161700E-03 |
| Normal-vs-Stage2 |
2.440300E-02 |
| Normal-vs-Stage3 |
9.359700E-03 |
| Normal-vs-Stage4 |
3.164400E-01 |
| Stage1-vs-Stage2 |
9.764200E-01 |
| Stage1-vs-Stage3 |
7.986000E-01 |
| Stage1-vs-Stage4 |
9.760200E-01 |
| Stage2-vs-Stage3 |
8.054800E-01 |
| Stage2-vs-Stage4 |
9.652400E-01 |
| Stage3-vs-Stage4 |
9.167400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.99147999999649E-05 |
| Normal-vs-AfricanAmerican |
7.587700E-04 |
| Normal-vs-Asian |
8.403200E-01 |
| Caucasian-vs-AfricanAmerican |
4.709400E-01 |
| Caucasian-vs-Asian |
4.004600E-01 |
| AfricanAmerican-vs-Asian |
2.981400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.584900E-04 |
| Normal-vs-Female |
1.598089999999E-05 |
| Male-vs-Female |
1.713960E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.319600E-02 |
| Normal-vs-Extreme_Weight |
1.404990E-03 |
| Normal-vs-Obese |
2.682300E-03 |
| Normal-vs-Extreme_Obese |
4.634400E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.949600E-01 |
| Normal_Weight-vs-Obese |
4.367200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.138000E-01 |
| Extreme_Weight-vs-Obese |
1.926620E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.654000E-01 |
| Obese-vs-Extreme_Obese |
1.192750E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.964700E-03 |
| Normal-vs-Age(41-60Yrs) |
5.43930000040938E-07 |
| Normal-vs-Age(61-80Yrs) |
3.382600E-03 |
| Normal-vs-Age(81-100Yrs) |
2.718400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.357600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.223800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.005400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.751700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.494000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.551600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.42920000000013E-05 |
| Normal-VS-Type2 PRCC |
1.742380E-03 |
| Normal-VS-KIRP CIMP |
3.955400E-01 |
| Normal-VS-Unclassified PRCC |
6.838000E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.587210E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.154400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.592240E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.369700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.490000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.113350E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.515600E-03 |
| Normal-vs-N1 |
4.069700E-02 |
| Normal-vs-N2 |
5.433000E-01 |
| N0-vs-N1 |
8.523000E-01 |
| N0-vs-N2 |
8.733000E-01 |
| N1-vs-N2 |
8.649200E-01 |
|
|
